Event JSON
{
"id": "51540542657fe7a441527c9f6cbd9453e3f03562dba6a38ec00a7a31c71841bf",
"pubkey": "1995e69af5f6996bfab16758064807f492ca377bc6a9f161446a29292d68dfce",
"created_at": 1745814268,
"kind": 1,
"tags": [
[
"t",
"clinicaltrials"
],
[
"t",
"asx"
],
[
"t",
"price"
],
[
"t",
"sec"
],
[
"proxy",
"https://mastodon-grafa.social/users/asx_news_en/statuses/114413683874447093",
"activitypub"
],
[
"client",
"Mostr",
"31990:6be38f8c63df7dbf84db7ec4a6e6fbbd8d19dca3b980efad18585c46f04b26f9:mostr",
"wss://relay.mostr.pub"
]
],
"content": "Radiopharm Theranostics doses first patient in US Phase 2b trial of 18F-RAD... - published 28 Apr 2025 #ClinicalTrials #ASX #price #SEC \nhttps://grafa.com/news/health-radiopharm-theranostics-doses-first-patient-in-us-phase-2b-trial-of-18f-rad101-for-brain-metastasis-425664?utm_source=asx_news_en\u0026utm_medium=mastodon\u0026utm_campaign=425664",
"sig": "9901cbac3f3cdc05750758b942b02bc1e05a55d9e1f386250c2d18353d6ddbce0a3fab48707626cfc8e3ea95c85c570bcf938c81a53fc072212f85fe5cbc4c17"
}